Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prognostic markers for prostate cancer].

M Graefen1, P Hammerer, J Noldus

  • 1Urologische Klinik, Universitätskrankenhaus Eppendorf, Hamburg.

Der Urologe. Ausg. A
|February 9, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Constraints on General Neutrino Interactions Based on KATRIN Data.

Physical review letters·2025
Same author

Impact of peritoneal bladder flap in robot-assisted radical prostatectomy patients on lymphoceles: a prospective randomised trial.

World journal of urology·2025
Same author

Corrigendum to "A standard operating technique to facilitate early return of urinary continence after robotic prostatectomy outcomes of a consensus meeting of experts with experience of over 30,000 cases" [Eur Urol Suppl 2017;16;e2301-2].

European urology open science·2021
Same author

[Non-invasive precursor lesions of penile carcinoma : Differential diagnosis and treatment].

Der Urologe. Ausg. A·2021
Same author

[Quality criteria in urology : How to obtain comparable results?]

Der Urologe. Ausg. A·2021
Same author

Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence.

World journal of urology·2020
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
See all related articles

Accurate prostate cancer prognosis relies on precisely estimating high-grade cancer proportion. Standardized biopsies and quantified analysis are key, as newer molecular markers are not yet practical for routine use.

Area of Science:

  • Oncology
  • Pathology

Context:

  • Prostate cancer treatment planning requires accurate prognostic markers.
  • Traditional prognostic factors often lack independent predictive value in multivariate analysis.
  • Estimating the proportion of high-grade cancer is crucial for therapeutic decisions.

Purpose:

  • To highlight the importance of accurate high-grade cancer proportion estimation in prostate cancer prognosis.
  • To evaluate the utility of standardized biopsy techniques and quantified analysis.
  • To discuss the current limitations of molecular biological markers in routine clinical practice.

Summary:

  • Accurate prostate cancer prognosis depends on precisely quantifying the proportion of high-grade cancer.
  • Standardized biopsy techniques and quantified analysis of biopsy cores are essential for reliable estimation.

Related Experiment Videos

  • While molecular markers show promise, their high cost and technical demands currently limit widespread clinical adoption.

    • Impact:

    • Improved accuracy in prostate cancer prognosis can lead to more personalized and effective treatment strategies.
    • Standardized diagnostic methods can enhance the reliability of prognostic assessments.
    • Further research into cost-effective molecular markers may improve future prostate cancer management.